Splunk Licenses

The contract involves procuring Splunk licenses to implement a comprehensive end-to-end solution aimed at monitoring end user activities across a hybrid environment that integrates both on-premises and cloud-based system components. The primary goal is to enhance the enterprise-wide system health monitoring, audit capabilities, and usage tracking, while also enabling real-time detection of cybersecurity threats. This solution is intended to support the Food and Drug Administration's efforts to maintain robust system oversight and security. This procurement falls under the NAICS code 541519 and is currently listed as a forecast with no solicitation number assigned yet. The Food and Drug Administration is the contracting agency, with the Program Point of Contact available via email, while the contracting officer details are yet to be determined. The contract does not specify set-aside details or the exact location for performance. The opportunity is accessible through the FDA's industry forecast platform, indicating intent to strengthen cybersecurity and operational monitoring through advanced technology solutions like Splunk.